- Home
- GIFT vs DYAI Comparison
GIFT vs DYAI Comparison
Compare GIFT & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GIFT | DYAI |
|---|---|---|
| Founded | 1999 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.6M | 30.2M |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | GIFT | DYAI |
|---|---|---|
| Price | $1.08 | $0.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $4.00 | $3.00 |
| AVG Volume (30 Days) | 26.5K | ★ 523.8K |
| Earning Date | 11-10-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $86,142,442.00 | $3,342,195.00 |
| Revenue This Year | N/A | $12.52 |
| Revenue Next Year | $7.20 | $92.04 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.82 | $0.71 |
| 52 Week High | $2.38 | $2.20 |
Technical Indicators
Market Signals| Indicator | GIFT | DYAI |
|---|---|---|
| Relative Strength Index (RSI) | 47.77 | 51.47 |
| Support Level | $1.07 | $0.93 |
| Resistance Level | $1.14 | $1.02 |
| Average True Range (ATR) | 0.05 | 0.09 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 27.78 | 48.53 |
Price Performance
Historical ComparisonAbout GIFT RDE Inc. Common Stock
Giftify Inc through its wholly-owned subsidiary, has been in the business of connecting digital consumers, businesses and communities with dining and merchant deal options throughout the United States. The company connects digital consumers, businesses, and communities offering dining and merchant deal options nationwide restaurants, and retailers to customers. The Company buys merchant gift cards from the general public and distributors at a discount and then resells them at a markup.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.